Search

Your search keyword '"Janarthanan, Mahesh"' showing total 120 results

Search Constraints

Start Over You searched for: Author "Janarthanan, Mahesh" Remove constraint Author: "Janarthanan, Mahesh"
120 results on '"Janarthanan, Mahesh"'

Search Results

1. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial

2. Tofacitinib for Refractory Uveitis and Scleritis in Children: A Case Series.

3. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort

4. Exploring clinical features and therapeutic outcomes in Indian children with mixed connective tissue disease: A multicenter study.

6. Rheumatological Presentation of Inborn Errors of Immunity in Children: A Case Series from a Tertiary Care Center.

8. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial

12. Gender differences in juvenile systemic sclerosis patients : Results from the international juvenile scleroderma inception cohort

15. Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohort

18. Diffuse juvenile systemic sclerosis patients show distinct organ involvement and have more severe disease in the largest jSSc cohort of the world. Results from the the juvenile scleroderma inception cohort

19. Juvenile systemic sclerosis treatment practices in an international cohort and comparison to recent SHARE consensus guidelines

20. Clinical characteristics of juvenile onset systemic sclerosis patients from the juvenile scleroderma inception cohort compared to adult age juvenile-onset patients from EUSTAR. Are these differences suggesting risk for mortality?

21. Patient and physician reported outcomes of juvenile systemic sclerosis patients significantly improve over 12 months observation period in the juvenile systemic scleroderma inception cohort

22. Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis

24. sj-pdf-1-jso-10.1177_23971983221143244 – Supplemental material for Gender differences in juvenile systemic sclerosis patients: Results from the international juvenile scleroderma inception cohort

25. Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis

29. Familial Blau syndrome:First molecularly confirmed report from India

36. Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part three

37. Do Raynaud phenomenon negative juvenile systemic scleroderma patients have a different pattern of organ involvement as Raynaud phenomenon positive patients?

38. AB0967 IS THERE A DIFFERENCE IN PRESENTATION OF FEMALE AND MALE PATIENTS WITH JUVENILE SYSTEMIC SCLERODERMA. AN UPDATE FROM THE JUVENILE SYSTEMIC SCLERODERMA INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM

39. SAT0479 UPDATE FROM THE JUVENILE SCLERODERMA INCEPTION COHORT. WWW.JUVENILE-SCLERODERMA.COM

43. Update from the Juvenile Scleroderma Inception Cohort

44. Is there a Difference in the Presentation of male and female Patients with diffuse subtype of juvenile systemic Sclerosis? Results from the juvenile Scleroderma Inception Cohort www.juvenile-scleroderma.com

45. Update on the juvenile systemic Sclerosis Inception Cohort Project. Characteristics of the first 97 Patients at first Assessment. www.juvenile-scleroderma.com

48. Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort

Catalog

Books, media, physical & digital resources